These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29523333)

  • 1. I3-Ag85 effect on phthiodiolone dimycocerosate synthesis.
    Rens C; Laval F; Wattiez R; Lefèvre P; Dufrasne F; Daffé M; Fontaine V
    Tuberculosis (Edinb); 2018 Jan; 108():93-95. PubMed ID: 29523333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.
    Bailo R; Bhatt A; Aínsa JA
    Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria.
    Rens C; Laval F; Daffé M; Denis O; Frita R; Baulard A; Wattiez R; Lefèvre P; Fontaine V
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6193-9. PubMed ID: 27503643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
    Warrier T; Tropis M; Werngren J; Diehl A; Gengenbacher M; Schlegel B; Schade M; Oschkinat H; Daffe M; Hoffner S; Eddine AN; Kaufmann SH
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1735-43. PubMed ID: 22290959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.
    Soetaert K; Rens C; Wang XM; De Bruyn J; Lanéelle MA; Laval F; Lemassu A; Daffé M; Bifani P; Fontaine V; Lefèvre P
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5057-60. PubMed ID: 26033733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
    Tahlan K; Wilson R; Kastrinsky DB; Arora K; Nair V; Fischer E; Barnes SW; Walker JR; Alland D; Barry CE; Boshoff HI
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
    Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
    J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors.
    Bosne-David S; Barros V; Verde SC; Portugal C; David HL
    J Antimicrob Chemother; 2000 Sep; 46(3):391-5. PubMed ID: 10980165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aloe Emodin Reduces Phthiodiolone Dimycocerosate Potentiating Vancomycin Susceptibility on Mycobacteria.
    Rens C; Ceyssens PJ; Laval F; Lefèvre P; Mathys V; Daffé M; Fontaine V
    Indian J Microbiol; 2018 Sep; 58(3):393-396. PubMed ID: 30013284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
    Xu W; DeJesus MA; Rücker N; Engelhart CA; Wright MG; Healy C; Lin K; Wang R; Park SW; Ioerger TR; Schnappinger D; Ehrt S
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of efflux pumps in the resistance to peptidoglycan synthesis inhibitors in Mycobacterium tuberculosis.
    Dinesh N; Sharma S; Balganesh M
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1941-3. PubMed ID: 23335736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype.
    Toro JC; Hoffner S; Linde C; Andersson M; Andersson J; Grundström S
    Microbes Infect; 2006 Jul; 8(8):1985-93. PubMed ID: 16793311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design.
    Singh G; Kumar A; Maan P; Kaur J
    Curr Drug Targets; 2017 Nov; 18(16):1904-1918. PubMed ID: 28699515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of trehalose analogs as potential inhibitors of mycobacterial cell wall biosynthesis.
    Rose JD; Maddry JA; Comber RN; Suling WJ; Wilson LN; Reynolds RC
    Carbohydr Res; 2002 Feb; 337(2):105-20. PubMed ID: 11814442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lipid metabolism-targeting compounds active against drug-resistant M. tuberculosis.
    Singh AK; Karaulia P; Yadav P; Narender T; Singh SP; Sashidhara KV; Pandey AK; Chopra S; Dasgupta A
    J Glob Antimicrob Resist; 2016 Dec; 7():26-27. PubMed ID: 27552738
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential Drug Targets in Mycobacterial Cell Wall: Non-Lipid Perspective.
    Das S; Hameed S; Fatima Z
    Curr Drug Discov Technol; 2020; 17(2):147-153. PubMed ID: 29875004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.
    Jackson M; McNeil MR; Brennan PJ
    Future Microbiol; 2013 Jul; 8(7):855-75. PubMed ID: 23841633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis.
    Blanchard JS
    Annu Rev Biochem; 1996; 65():215-39. PubMed ID: 8811179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.
    Gonzalo X; Casali N; Broda A; Pardieu C; Drobniewski F
    Int J Antimicrob Agents; 2015 Apr; 45(4):406-12. PubMed ID: 25717028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.